Prof. Dr. med. Carola Berking



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy - A multicenter study on 2419 patients from the prospective skin cancer registry ADOReg. (2025) Kött J, Zell T, Zimmermann N, Rünger A, Smit DJ, Abeck F, Geidel G, et al. Journal article Prospective multicenter study using artificial intelligence to improve dermoscopic melanoma diagnosis in patient care (2024) Heinlein L, Maron RC, Hekler A, Haggenmüller S, Wies C, Utikal JS, Meier F, et al. Journal article Metastasiertes ekkrines Porokarzinom bei einem jungen Patienten (2024) Kramer R, Agaimy A, Berking C, Erdmann M Journal article Bäckerasthma bei der Lakritzherstellung? (2024) Azem T, Sticherling M, Berking C, Wagner N Journal article 100 Jahre Universitätshautklinik in Erlangen: Ein Beispiel für die Emanzipierung des Faches Dermatologie (2024) Sticherling M, Berking C Journal article General practitioners’ perspectives on statutory skin cancer screening–A questionnaire-based cross-sectional survey in Germany (2024) Reinhardt L, Strasser C, Steeb T, Petzold A, Heppt M, Wessely A, Berking C, Meier F Journal article 100 Jahre Hautklinik Erlangen (2024) Leistner L, Sticherling M, Berking C, Leven KH Journal article Gleichzeitiges Auftreten zweier malignomverdächtiger Hautveränderungen (2024) Kaufmann M, Erdmann M, Schliep S, Voskens C, Berking C, Bauerschmitz J Journal article Checkpoint inhibitor–induced lichen planus differs from spontaneous lichen planus on the clinical, histological, and gene expression level (2024) Meier-Schiesser B, Zecha C, Zierold S, Kolm I, Röckel M, Fröhlich W, Mittag N, et al. Journal article Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapy (2024) Lischer C, Eberhardt M, Flamann C, Berges J, Güse E, Wessely A, Weich A, et al. Journal article